Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07807059

1 development in the corpus

NCT07807059

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 1 TRIAL

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

ClinicalTrials.gov

Phase 1 single-dose pharmacokinetic study in a small, planned cohort with no results yet posted; registry record only describes the protocol.

PreliminaryNCT07807059 Metabolic Dysfunction Associated Steatotic Liver Disease/steatohepatitis (MASLD/HRS-4729

Reported

Planned sample size32

Allocation: healthy participants8

Allocation: mild renal impairment8

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support